A federal proposal targeting Medicare Advantage payments sent Louisville-based Humana’s stock down about 20% Tuesday and ...

Humana stock plunged 21% after a shockingly low Medicare Advantage rate proposal threatens margins and clouds the insurer’s outlook.

A federal judge has thrown out a last-ditch effort from Humana to get the government to recalculate its Medicare Advantage star ratings for 2025. On Tuesday, Judge Reed O’Connor of the Texas Northern ...

Humana is convinced that it can grow both the size and profitability of its Medicare Advantage business in 2026, despite concerns that the insurer’s plans are too generous and could saddle the company ...

Health insurer stocks are tumbling after the market close on Monday following a report indicating the Trump administration will propose essentially unchanged rates for Medicare insurers next year.

Humana's stock has declined 18% while the S&P 500 returned 13.5%, driven by short-term issues with Medicare Advantage. Despite short-term cost challenges, Medicare Advantage remains a long-term ...

The CMS proposed modest payment growth for Medicare Advantage in 2027 and emphasized sustainability, accuracy, and simplicity.

Humana plans to achieve 4 stars in its Medicare Advantage star rating in 2028, according to information released during its Investor Conference on Monday. Humana told investors that it doesn't foresee ...

Humana said Thursday that about 20% of its members are currently enrolled in plans that will have at least four stars, based on preliminary data on the 2026 star ratings for Medicare Advantage (MA).

Ross and Bannow reviewed internal documents and government reports and spoke with dozens of people, including former Humana employees, to report this story. Tara Bannow covers hospitals, providers, ...

More than 80% of Humana Medicare Advantage members will be in plans with stable benefits. Humana Medicare Advantage plans include preventive and diagnostic screenings for breast cancer, colon cancer ...